Ritu Baral
Stock Analyst at TD Cowen
(4.98)
# 66
Out of 5,119 analysts
1054
Total ratings
51.1%
Success rate
41.9%
Average return
Main Sectors:
Stocks Rated by Ritu Baral
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $37 | $21.23 | +74.28% | 67 | Nov 5, 2026 | |
| KRYS Krystal Biotech | Reiterated: Buy | $403 → $380 | $300.88 | +26.30% | 43 | Nov 3, 2026 | |
| ALNY Alnylam Pharmaceuticals | Rated: Buy | $482 → $354 | $155.94 | +127.01% | 103 | Oct 29, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Hold | $17 | $17.82 | -4.60% | 105 | Oct 21, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $71 | $46.94 | +51.26% | 7 | Oct 21, 2026 | |
| IVA Inventiva | Reiterated: Buy | $10 | $3.80 | +163.16% | 9 | Sep 28, 2026 | |
| BNTC Benitec Biopharma | Reiterated: Buy | n/a | $9.54 | - | 6 | Sep 15, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $78 | $29.79 | +161.88% | 27 | Aug 31, 2026 | |
| OVID Ovid Therapeutics | Reiterated: Buy | n/a | $2.85 | - | 25 | Aug 13, 2026 | |
| MIST Milestone Pharmaceuticals | Reiterated: Buy | $8 | $0.7628 | +948.77% | 36 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.31 | - | 24 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $21.03 | +218.59% | 4 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.61 | - | 15 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $243 | $114.41 | +112.40% | 73 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.18 | - | 2 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $510 | $277.62 | +83.70% | 28 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $8.61 | +236.82% | 23 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $267 | $175.92 | +51.77% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $644 | $399.63 | +61.15% | 45 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.28 | - | 9 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $15.52 | +196.39% | 1 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €8.94 | €3.40 | +162.97% | 8 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.16 | - | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $9.85 | +113.20% | 18 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.03 | - | 25 | Nov 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.75 | - | 15 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.114 | n/a | 37 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.3602 | n/a | 11 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.00 | n/a | 5 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.8097 | n/a | 12 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20.75 → $20.41 | $2.00 | n/a | 7 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $46.55 | n/a | 2 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $20.64 | n/a | 11 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $39.42 | n/a | 9 | Feb 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $13.54 | n/a | 22 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $65.44 | n/a | 37 | May 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.43 | n/a | 8 | Jan 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $21.70 | n/a | 17 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0111 | n/a | 23 | Oct 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.18 | n/a | 4 | Jul 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.6337 | n/a | 14 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $53.69 | n/a | 22 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $28.49 | n/a | 7 | Apr 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.98 | n/a | 7 | Mar 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.83 | n/a | 6 | Dec 30, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $29 | $0.9578 | n/a | 2 | May 15, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $291 → $355 | $248.35 | n/a | 5 | Jan 27, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $1.6 | $11.61 | n/a | 17 | Nov 18, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $3 | $0.0001 | n/a | 7 | Jul 9, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $6 | $2.54 | n/a | 5 | Jun 25, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.05 | n/a | 3 | Jun 18, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $13 | $16.92 | n/a | 1 | Mar 14, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $7.73 | n/a | 1 | Feb 21, 2012 |
Acadia Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $37
Current: $21.23
Upside: +74.28%
Krystal Biotech
Nov 3, 2026
Reiterated: Buy
Price Target: $403 → $380
Current: $300.88
Upside: +26.30%
Alnylam Pharmaceuticals
Oct 29, 2026
Rated: Buy
Price Target: $482 → $354
Current: $155.94
Upside: +127.01%
Sarepta Therapeutics
Oct 21, 2026
Reiterated: Hold
Price Target: $17
Current: $17.82
Upside: -4.60%
Scholar Rock Holding
Oct 21, 2026
Reiterated: Buy
Price Target: $71
Current: $46.94
Upside: +51.26%
Inventiva
Sep 28, 2026
Reiterated: Buy
Price Target: $10
Current: $3.80
Upside: +163.16%
Benitec Biopharma
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.54
Upside: -
Vera Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $78
Current: $29.79
Upside: +161.88%
Ovid Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $2.85
Upside: -
Milestone Pharmaceuticals
Aug 12, 2026
Reiterated: Buy
Price Target: $8
Current: $0.7628
Upside: +948.77%
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.31
Upside: -
Aug 7, 2026
Reiterated: Buy
Price Target: $67
Current: $21.03
Upside: +218.59%
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.61
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $243
Current: $114.41
Upside: +112.40%
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.18
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: $510
Current: $277.62
Upside: +83.70%
Aug 5, 2026
Reiterated: Buy
Price Target: $29
Current: $8.61
Upside: +236.82%
Aug 4, 2026
Reiterated: Buy
Price Target: $267
Current: $175.92
Upside: +51.77%
Jul 30, 2026
Reiterated: Buy
Price Target: $644
Current: $399.63
Upside: +61.15%
Jul 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.28
Upside: -
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $15.52
Upside: +196.39%
Jun 8, 2026
Reiterated: Buy
Price Target: €8.94
Current: €3.40
Upside: +162.97%
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.16
Upside: -
May 12, 2026
Reiterated: Buy
Price Target: $21
Current: $9.85
Upside: +113.20%
Nov 16, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.03
Upside: -
Nov 10, 2025
Reiterated: Buy
Price Target: n/a
Current: $15.75
Upside: -
Aug 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.114
Upside: n/a
Aug 11, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.3602
Upside: n/a
Apr 11, 2025
Reiterated: Hold
Price Target: n/a
Current: $4.00
Upside: n/a
Feb 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.8097
Upside: n/a
Apr 18, 2023
Downgraded: Hold
Price Target: $20.75 → $20.41
Current: $2.00
Upside: n/a
Nov 23, 2021
Downgraded: Hold
Price Target: n/a
Current: $46.55
Upside: n/a
Mar 16, 2020
Reiterated: Buy
Price Target: n/a
Current: $20.64
Upside: n/a
Feb 27, 2020
Reiterated: Hold
Price Target: n/a
Current: $39.42
Upside: n/a
Feb 24, 2020
Reiterated: Buy
Price Target: n/a
Current: $13.54
Upside: n/a
May 8, 2019
Reiterated: Hold
Price Target: n/a
Current: $65.44
Upside: n/a
Jan 6, 2019
Reiterated: Buy
Price Target: n/a
Current: $15.43
Upside: n/a
Dec 3, 2018
Reiterated: Buy
Price Target: n/a
Current: $21.70
Upside: n/a
Oct 12, 2018
Rated: Hold
Price Target: n/a
Current: $0.0111
Upside: n/a
Jul 2, 2018
Downgraded: Hold
Price Target: n/a
Current: $3.18
Upside: n/a
Apr 6, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.6337
Upside: n/a
Apr 6, 2018
Reiterated: Hold
Price Target: n/a
Current: $53.69
Upside: n/a
Apr 6, 2018
Reiterated: Hold
Price Target: n/a
Current: $28.49
Upside: n/a
Mar 16, 2017
Reiterated: Buy
Price Target: n/a
Current: $1.98
Upside: n/a
Dec 30, 2016
Rated: Hold
Price Target: n/a
Current: $4.83
Upside: n/a
May 15, 2014
Rated: Buy
Price Target: $25 → $29
Current: $0.9578
Upside: n/a
Jan 27, 2014
Reiterated: Buy
Price Target: $291 → $355
Current: $248.35
Upside: n/a
Nov 18, 2013
Initiated Coverage: Hold
Price Target: $1.6
Current: $11.61
Upside: n/a
Jul 9, 2012
Reiterated: Buy
Price Target: $6 → $3
Current: $0.0001
Upside: n/a
Jun 25, 2012
Reiterated: Hold
Price Target: $8 → $6
Current: $2.54
Upside: n/a
Jun 18, 2012
Reiterated: Buy
Price Target: $6
Current: $1.05
Upside: n/a
Mar 14, 2012
Upgraded: Buy
Price Target: $13
Current: $16.92
Upside: n/a
Feb 21, 2012
Reiterated: Buy
Price Target: $14
Current: $7.73
Upside: n/a